Medtronic plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDT research report →
Range $80 – $119
Price Chart
About the company
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software.
- CEO
- Geoffrey Straub Martha
- IPO
- 1973
- Employees
- 95,000
- HQ
- Galway, GA, IE
Get TickerSpark's AI analysis on MDT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $104.76B
- P/E
- 21.82
- Fwd P/E
- 13.74
- PEG
- 6.60
- P/S
- 2.88
- P/B
- 2.12
- EV/EBITDA
- 13.46
- Div Yield
- 3.48%
- Gross Margin
- 65.02%
- Op Margin
- 17.78%
- Net Margin
- 13.20%
- ROE
- 9.85%
- ROIC
- 6.13%
Latest fiscal year · YoY change
- Revenue
- $36.36B+8.4%
- Gross Profit
- $23.64B+7.9%
- Op Income
- $6.47B
- Net Income
- $4.80B+3.0%
- EPS
- $3.75+3.3%
- OCF Growth
- +4.1%
- FCF Growth
- +4.6%
- 52W High
- $106.33
- 52W Low
- $73.31
- 50D MA
- $79.53
- 200D MA
- $90.60
- Beta
- 0.58
- RSI (14)
- 51
- Avg Volume
- 10.19M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Get the MDT Q4 '26 earnings-call summary
Create a free account to generate an AI summary of this call — key takeaways, results & guidance, CEO/CFO commentary, Q&A, and a bull vs bear read. Ready in about a minute, and it'll be live for everyone.
Create free account →Already have an account? Log in
- Free Float
- 99.8%
- Shares Outstanding
- 1.28B
- Float Shares
- 1.28B
of shares held by institutions
2,288 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for MDT, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Gilbert CisnerosHouse · CA31 | Sell | May 15, 26 | Filing → |
| Kevin HernHouse · OK01 | Sell | Mar 20, 26 | Filing → |
| Julie JohnsonHouse · TX32 | Sell | Dec 18, 25 | Filing → |
| Julie JohnsonHouse · TX32 | Sell | Nov 13, 25 | Filing → |
| Rich McCormickHouse | Buy | Nov 5, 25 | Filing → |
| Richard Dean Dr McCormickHouse · GA06 | Buy | Mar 15, 23 | Filing → |
| Julie JohnsonHouse · TX32 | Sell | Aug 14, 25 | Filing → |
| Ro KhannaHouse · CA17 | Sell | Jun 27, 25 | Filing → |
| Rob BresnahanHouse · PA08 | Buy | May 15, 25 | Filing → |
| Rob BresnahanHouse · PA08 | Sell | Apr 8, 25 | Filing → |
| George WhitesidesHouse · CA27 | Sell | Mar 24, 25 | Filing → |
| Bruce WestermanHouse · AR04 | Sell | Mar 20, 25 | Filing → |
| Bruce WestermanHouse · AR04 | Buy | Mar 4, 25 | Filing → |
| Rob BresnahanHouse · PA08 | Buy | Feb 25, 25 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 128.96M | ▲ 1.89M |
| Blackrock, Inc. | 113.18M | ▼ 7.36M |
| State Street Corp | 61.74M | ▲ 80.86K |
| Jpmorgan Chase & Co | 50.97M | ▼ 2.64M |
| Capital Research Global Investors | 41.93M | ▲ 7.35M |
| Geode Capital Management, LLC | 28.74M | ▲ 856.86K |
| Bank Of America Corp | 26.02M | ▲ 1.34M |
| Massachusetts Financial Services Co | 21.44M | ▲ 489.64K |
| Morgan Stanley | 20.72M | ▲ 494.45K |
| Deutsche Bank AG\ | 19.00M | ▲ 1.25M |
| Norges Bank | 17.21M | ▲ 17.21M |
| Invesco Ltd. | 16.79M | ▲ 554.71K |
Held by 643 ETFs
Biggest fund positions in MDT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 8, 26 | Walter Matthew R. | sell | 3,102 |
| Jun 18, 26 | Thompson Kweli | other | 0 |
| Jun 18, 26 | Thompson Kweli | other | 3,252.987 |
| Jun 18, 26 | Thompson Kweli | other | 9,178.809 |
| Aug 1, 17 | Thompson Kweli | other | 1,704 |
| Jan 30, 18 | Thompson Kweli | other | 1,608 |
| Jul 31, 18 | Thompson Kweli | other | 4,407 |
| Jul 30, 19 | Thompson Kweli | other | 6,271 |
| Jul 29, 20 | Thompson Kweli | other | 1,615 |
| Aug 3, 21 | Thompson Kweli | other | 10,181 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MDT coverage
Recent articles, reports, and earnings notes.
Medtronic (MDT): Broad-Based Growth Is Finally Accelerating
Medtronic is showing its strongest top-line growth in a decade, led by cardiovascular and pulsed field ablation momentum. The stock looks like a balanced Buy for moderate-risk investors, though margin pressure and debt keep the turnaround case from being pristine.
Medtronic plc (MDT) rises 5.9% on strong earnings outlook
Medtronic plc (MDT) rises after reporting fiscal Q4 2026 results that showed stronger revenue growth, standout cardiovascular performance, and upbeat FY27 guidance. Investors are responding to a cleaner growth narrative as the medical device giant signals improving momentum and solid cash generation.
Medtronic may have finally found its second act
Medtronic finally has a growth story that looks big enough to matter at the company level, not just in a niche product line. With cardiac ablation surging and valuation still well below faster-loved device peers, MDT looks like the more compelling catch-up trade here.
Want a deeper read on MDT?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Orchestra BioMed: Nearing The First Of Two Pivotal Readouts
seekingalpha.com · Jul 22
Medtronic (MDT) Stock Declines While Market Improves: Some Information for Investors
zacks.com · Jul 21
A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026
prnewswire.com · Jul 21
Andra AP fonden Trims Stock Holdings in Medtronic PLC $MDT
defenseworld.net · Jul 21
Medtronic to announce financial results for its first quarter of fiscal year 2027
prnewswire.com · Jul 20
Decker Wealth Management LLC Invests $5.08 Million in Medtronic PLC $MDT
defenseworld.net · Jul 20
Medtronic PLC $MDT Shares Sold by Allspring Global Investments Holdings LLC
defenseworld.net · Jul 18
Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain
prnewswire.com · Jul 16
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
Bullish or bearish?
Where do you stand on MDT?